BRPI0923853A2 - análogos de gpl-1 e usos dos mesmos. - Google Patents

análogos de gpl-1 e usos dos mesmos.

Info

Publication number
BRPI0923853A2
BRPI0923853A2 BRPI0923853A BRPI0923853A BRPI0923853A2 BR PI0923853 A2 BRPI0923853 A2 BR PI0923853A2 BR PI0923853 A BRPI0923853 A BR PI0923853A BR PI0923853 A BRPI0923853 A BR PI0923853A BR PI0923853 A2 BRPI0923853 A2 BR PI0923853A2
Authority
BR
Brazil
Prior art keywords
gpl
analogs
Prior art date
Application number
BRPI0923853A
Other languages
English (en)
Inventor
Rajesh Jain
Sudhanand Prasad
Virender Kumar Vinayak
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of BRPI0923853A2 publication Critical patent/BRPI0923853A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0923853A 2008-12-29 2009-12-24 análogos de gpl-1 e usos dos mesmos. BRPI0923853A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2956DE2008 2008-12-29
PCT/IN2009/000742 WO2010076809A2 (en) 2008-12-29 2009-12-24 Glp-1 analogs and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0923853A2 true BRPI0923853A2 (pt) 2016-01-12

Family

ID=42310290

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923853A BRPI0923853A2 (pt) 2008-12-29 2009-12-24 análogos de gpl-1 e usos dos mesmos.

Country Status (7)

Country Link
US (1) US20110269680A1 (pt)
EP (1) EP2384338A4 (pt)
JP (1) JP2012513981A (pt)
AU (1) AU2009334289A1 (pt)
BR (1) BRPI0923853A2 (pt)
RU (1) RU2011131714A (pt)
WO (1) WO2010076809A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110452952B (zh) * 2018-05-08 2024-01-16 宜昌东阳光长江药业股份有限公司 一种glp-1类似物生物活性的检测方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
PL208751B1 (pl) * 1998-12-07 2011-06-30 Sod Conseils Rech Applic Związki stanowiące analogi GLP-1, kompozycje zawierające takie związki oraz zastosowanie takich związków
CA2358107C (en) * 1998-12-22 2011-08-23 Eli Lilly And Company Shelf-stable formulation of glucagon-like peptide-1
EP1411968B1 (en) * 2001-07-31 2008-09-17 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Glp-1 exendin-4 peptide analogs and uses thereof
EP1709071A4 (en) * 2004-01-08 2007-05-30 Theratechnologies Inc GLUCAGON LIKE PEPTIDE-1 ANALOGS WITH LONG PERFORMANCE
ES2542228T3 (es) * 2004-07-08 2015-08-03 Novo Nordisk A/S Marcas de prolongación polipeptídica que comprenden un resto de tetrazol
WO2006010143A2 (en) * 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
WO2007030706A1 (en) * 2005-09-08 2007-03-15 New England Medical Center Hospitals, Inc. Fragments of the glucagon-like peptide-i and uses thereof
EP1943275B1 (en) * 2005-11-01 2010-06-16 Activotec SPP Limited Insulinotropic compounds and uses thereof
JPWO2007063907A1 (ja) * 2005-11-30 2009-05-07 塩野義製薬株式会社 ペプチド糖鎖付加体およびそれを有効成分とする医薬
EP2007804B1 (en) * 2006-04-20 2014-06-18 Amgen, Inc Glp-1 compounds
US8598314B2 (en) * 2007-09-27 2013-12-03 Amylin Pharmaceuticals, Llc Peptide-peptidase-inhibitor conjugates and methods of making and using same

Also Published As

Publication number Publication date
EP2384338A2 (en) 2011-11-09
EP2384338A4 (en) 2013-01-16
US20110269680A1 (en) 2011-11-03
WO2010076809A3 (en) 2010-08-26
RU2011131714A (ru) 2013-02-10
AU2009334289A1 (en) 2011-07-28
WO2010076809A2 (en) 2010-07-08
WO2010076809A4 (en) 2010-09-23
JP2012513981A (ja) 2012-06-21

Similar Documents

Publication Publication Date Title
BRPI1013943A2 (pt) Composto cetais e usos dos mesmos.
BRPI0920927A2 (pt) derivados de azaquinolinona e usos dos mesmos
BRPI0914682A2 (pt) compostos de heteroarila e usos dos mesmos
BRPI0912198A2 (pt) anticorpos anti-fn14 e usos dos mesmos
BRPI0922689A2 (pt) conjugados de neurotensina ou análogos de neurotensina e usos dos mesmos
BRPI0909469A2 (pt) compostos de oximetileno de arila e usos dos mesmos
BRPI0922691A2 (pt) conjugados de leptina e análogo de leptina e usos dos mesmos
BRPI0818477A2 (pt) Dc-sign, icam-3 e lsectin porcinos e usos dos mesmos
BRPI1011970A2 (pt) compostos pirazolil-acrilonitrila e usos dos mesmos.
BRPI0920521A2 (pt) combinação farmacêutica
BRPI0817269A2 (pt) Análogos de azacitidina e usos dos mesmos
DE112009004699A5 (de) Elektrochirurgisches System
BR112013015592A8 (pt) derivados de biciclo-[3.2.1]-octilamida e usos dos mesmos
BRPI1009455A2 (pt) anticorpos anti-c40 e usos dos mesmos
BRPI0918502A2 (pt) aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
PL2452709T3 (pl) Kaniula
EP2364330A4 (en) MULTI BLOCK POLYMERS
BRPI0822337A2 (pt) Folatos, composições e usos dos mesmos
BRPI0921327A2 (pt) Combinação de herbicida-protetor
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0915142A2 (pt) polipeptídeos, ácido nucleico e usos dos mesmos
BRPI1016117A2 (pt) derivados de isoxazol-isoxazol e isoxasol-isotiazol.
BRPI0814876A2 (pt) Análogos de pirona fosforilados e métodos
BRPI0921230A2 (pt) agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo.
BRPI0914900A2 (pt) compostos de amida, métodos de preparação e usos dos mesmos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]